Berkeley, California
United States
58
2022-09-22
54
2023-11-28
These are the the leading inventors for applications assigned to Dynavax Technologies Corporation:
Dynavax Technologies Corporation based in Berkeley, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Toll-like receptor antagonist compounds and methods of use
#2 | 2019-11-14 ✅ Patent 11,370,794 granted on 2022-06-28Toll-like receptor antagonist compounds and methods of use
#3 | 2019-08-08 ✅ Patent 10,548,975 granted on 2020-02-04Branched chimeric compounds, and methods of use thereof
#4 | 2019-05-23 ✅ Patent 10,722,591 granted on 2020-07-28Cleavable conjugates of TLR7/8 agonist compounds, methods for preparation, and uses thereof
#5 | 2019-05-23 ✅ Patent 10,369,168 granted on 2019-08-06Administration of polynucleotide toll-like receptor 9 agonists for treating cancer
#6 | 2019-02-28 ✅ Patent 10,618,896 granted on 2020-04-14Alkyl chain modified imidazoquinoline TLR7/8 agonist compounds and uses thereof
#7 | 2018-12-20 ✅ Patent 10,350,290 granted on 2019-07-16Linear chimeric compounds and methods of use thereof
#8 | 2018-09-20 ✅ Patent 10,111,899 granted on 2018-10-30Intrapulmonary administration of polynucleotide toll-like receptor 9 agonists for treating cancer of the lung
#9 | 2018-08-30 ✅ Patent 10,314,907 granted on 2019-06-11Methods and compositions for eliciting an immune response against hepatitis B virus
#10 | 2018-06-21 ✅ Patent 10,751,412 granted on 2020-08-25Combination of a PD-1 antagonist and CPG-C type oligonucleotide for treating cancer
#11 | 2018-06-14COMBINATION OF AN ANTI-IL-10 ANTIBODY AND A CPG-C TYPE OLIGONUCLEOTIDE FOR TREATING CANCER
#12 | 2017-03-30 ✅ Patent 9,884,110 granted on 2018-02-06Methods and compositions for eliciting an immune response against hepatitis B virus
#13 | 2017-03-09 ✅ Patent 10,196,643 granted on 2019-02-05Immunostimulatory sequence oligonucleotides and methods of using the same
#14 | 2016-12-01 ✅ Patent 9,993,495 granted on 2018-06-12Intrapulmonary administration of polynucleotide toll-like receptor 9 agonists for treating cancer of the lung
#15 | 2016-07-28 ✅ Patent 9,950,064 granted on 2018-04-24Branched and linear chimeric compounds, polynucleotides, uses and methods for preparation thereof
#16 | 2016-01-07TLR8 TRANSGENIC ANIMALS
#17 | 2015-10-01 ✅ Patent 9,476,053 granted on 2016-10-25Methods and compositions for inhibition of immune responses and autoimmunity
#18 | 2015-09-10 ✅ Patent 9,868,955 granted on 2018-01-16Human toll-like receptor inhibitors and methods of use thereof
#19 | 2015-07-23 ✅ Patent 9,347,064 granted on 2016-05-24Methods of treatment using TLR7 and/or TLR9 inhibitors
#20 | 2015-05-14 ✅ Patent 9,422,564 granted on 2016-08-23Immunostimulatory sequence oligonucleotides and methods of using the same
#21 | 2015-01-22 ✅ Patent 9,333,254 granted on 2016-05-10Long term disease modification using immunostimulatory oligonucleotides
#22 | 2014-05-08 ✅ Patent 9,028,845 granted on 2015-05-12Chimeric immunomodulatory compounds and methods of using the same-IV
#23 | 2014-04-03 ✅ Patent 9,228,184 granted on 2016-01-05Human toll-like receptor inhibitors and methods of use thereof
#24 | 2013-06-20 ✅ Patent 8,940,310 granted on 2015-01-27Methods of treatment using TLR7 and/or TLR9 inhibitors
#25 | 2013-06-06 ✅ Patent 8,871,732 granted on 2014-10-28Immunostimulatory sequence oligonucleotides and methods of using the same
#26 | 2012-10-18 ✅ Patent 9,452,212 granted on 2016-09-27Methods and compositions for eliciting an immune response against hepatitis B virus
#27 | 2012-10-04 ✅ Patent 9,063,123 granted on 2015-06-23Transgenic mice expressing human toll-like receptor 8
#28 | 2012-09-13 ✅ Patent 8,597,665 granted on 2013-12-03Chimeric immunomodulatory compounds and methods of using the same-IV
#29 | 2012-05-17 ✅ Patent 8,669,237 granted on 2014-03-11Biodegradable immunomodulatory formulations and methods for use thereof
#30 | 2011-05-26METHODS AND COMPOSITIONS FOR INDUCTION OR PROMOTION OF IMMUNE TOLERANCE
#31 | 2011-05-19 ✅ Patent 8,815,817 granted on 2014-08-26Long term disease modification using immunostimulatory oligonucleotides
#32 | 2011-02-17 ✅ Patent 8,124,590 granted on 2012-02-28Biodegradable immunomodulatory formulations and methods for use thereof
#33 | 2011-01-06 ✅ Patent 8,962,579 granted on 2015-02-24Methods and compositions for inhibition of immune responses and autoimmunity
#34 | 2010-11-18 ✅ Patent 8,586,555 granted on 2013-11-19Immunomodulatory compositions, formulations, and methods for use thereof
#35 | 2010-08-31 ✅ Patent 7,785,610 granted on 2010-08-31Chimeric immunomodulatory compounds and methods of using the same—III
#36 | 2010-07-22 ✅ Patent 8,158,768 granted on 2012-04-17Immunostimulatory sequence oligonucleotides and methods of using the same
#37 | 2010-07-22METHODS OF REDUCING PAPILLOMAVIRUS INFECTION USING IMMUNOMODULATORY POLYNUCLEOTIDE SEQUENCES
#38 | 2010-06-01 ✅ Patent 7,727,712 granted on 2010-06-01Methods of suppressing hepatitis virus infection using immunomodulatory polynucleotide sequences
#39 | 2010-02-11 ✅ Patent 8,226,957 granted on 2012-07-24Methods of preventing and treating respiratory viral infection using immunomodulatory polynucleotide sequences
#40 | 2009-12-24 ✅ Patent 8,222,398 granted on 2012-07-17Chimeric immunomodulatory compounds and methods of using the same-II
#41 | 2009-12-01 ✅ Patent 7,625,872 granted on 2009-12-01Branched immunomodulatory compounds and methods of using the same
#42 | 2009-06-11 ✅ Patent 8,333,980 granted on 2012-12-18Methods of modulating an immune response using immunostimulatory sequences and compositions for use therein
#43 | 2009-03-12 ✅ Patent 8,252,757 granted on 2012-08-28Long term disease modification using immunostimulatory oligonucleotides
#44 | 2009-01-20 ✅ Patent 7,479,285 granted on 2009-01-20Methods of modulating an immune response using immunostimulatory sequences and compositions for use therein
#45 | 2009-01-15 ✅ Patent 7,884,083 granted on 2011-02-08Immunomodulatory compositions, methods of making, and methods of use thereof
#46 | 2008-08-28 ✅ Patent 8,372,413 granted on 2013-02-12Immunomodulatory polynucleotides and methods of using the same
#47 | 2008-07-31 ✅ Patent 8,003,115 granted on 2011-08-23Chimeric immunomodulatory compounds and methods of using the same
#48 | 2007-10-11 ✅ Patent 8,759,305 granted on 2014-06-24Methods and compositions for inhibition of innate immune responses and autoimmunity
#49 | 2007-08-16 ✅ Patent 7,628,990 granted on 2009-12-08Immunomodulatory compositions containing an immunostimulatory sequence linked to antigen and methods of use thereof
#50 | 2007-08-14 ✅ Patent 7,255,868 granted on 2007-08-14Chimeric immunomodulatory compounds and methods of using the same—I
#51 | 2007-07-31 ✅ Patent 7,250,403 granted on 2007-07-31Biodegradable immunomodulatory formulations and methods for use thereof
#52 | 2007-05-29 ✅ Patent 7,223,398 granted on 2007-05-29Immunomodulatory compositions containing an immunostimulatory sequence linked to antigen and methods of use thereof
#53 | 2007-03-01 ✅ Patent 8,114,418 granted on 2012-02-14Chimeric immunomodulatory compounds and methods of using the same—IV
#54 | 2007-02-27 ✅ Patent 7,183,111 granted on 2007-02-27Immunomodulatory formulations and methods for use thereof
#55 | 2007-02-15 ✅ Patent 7,718,622 granted on 2010-05-18Compositions comprising structurally stable conjugate molecules
#56 | 2006-11-23 ✅ Patent 7,157,437 granted on 2007-01-02Methods of ameliorating symptoms of herpes infection using immunomodulatory polynucleotide sequences
#57 | 2006-10-31 ✅ Patent 7,129,222 granted on 2006-10-31Immunomodulatory formulations and methods for use thereof
#58 | 2006-03-16 ✅ Patent 7,745,606 granted on 2010-06-29Immunostimulatory sequence oligonucleotides and methods of using the same
Also check out Dynavax Technologies Corporation's (Berkeley, United States) applicant profile with 21 patent applications submitted.
27048 ⎘